Increase in the concentration of immunoreactive endothelin in human pregnancy

1991 ◽  
Vol 129 (2) ◽  
pp. 301-307 ◽  
Author(s):  
I. Iwata ◽  
T. Takagi ◽  
K. Yamaji ◽  
O. Tanizawa
Keyword(s):  
Detection Limit ◽  
Amniotic Fluid ◽  
Vaginal Delivery ◽  
Umbilical Artery ◽  
Umbilical Vein ◽  
Plasma Concentrations ◽  
Late Pregnancy ◽  
Maternal Plasma ◽  
Fetal Plasma ◽  
The Mean

ABSTRACT Maternal plasma concentrations of immunoreactive endothelin (ir-ET) during pregnancy, labour and after birth were measured by radioimmunoassay. Concentrations of ir-ET in the umbilical artery, umbilical vein, amniotic fluid and neonatal urine were also examined. The mean (± s.e.m.) plasma ir-ET concentration in early pregnancy (4–7 weeks) was 13·7±0·5 pmol/l, which was significantly higher than that in non-pregnant women (5·9±0·3 pmol/l). During pregnancy, plasma ir-ET concentrations gradually decreased to a minimum of 11·5±0·4 pmol/l in weeks 20–23, and then increased again towards term (12·5±0·4 pmol/l after 36 weeks of pregnancy). In women undergoing vaginal delivery, the mean plasma ir-ET concentration (17·1±0·7 pmol/l) increased significantly, compared with that in late pregnancy. After delivery, the plasma ir-ET concentration decreased abruptly to 4·0±0·2 pmol/l on the first day. Plasma ir-ET concentrations in umbilical vessels were significantly higher than those in maternal plasma. In addition, concentrations in the umbilical artery were significantly higher than those in the umbilical vein in cases of vaginal delivery. Concentrations of ir-ET in amniotic fluid were much higher than those in maternal or fetal plasma. ir-ET concentrations in neonatal urine on day 1 after birth were below the detection limit (< 0·1 pmol/l) by radioimmunoassay in 70% of the cases examined but on day 5 after birth ir-ET was present at measurable concentrations in all cases. It is suggested that endothelin may act as a circulating hormone during pregnancy and labour in both maternal and fetal circulations. Journal of Endocrinology (1991) 129, 301–307

Thyroid and parathyroid-independent increase in plasma 1,25-dihydroxyvitamin D during late pregnancy in the rat

1988 ◽  
Vol 116 (3) ◽  
pp. 381-385 ◽  
Author(s):  
T. M. Nguyen ◽  
A. Halhali ◽  
H. Guillozo ◽  
M. Garabedian ◽  
S. Balsan
Keyword(s):  
Vitamin D ◽  
Placental Transfer ◽  
Plasma Concentrations ◽  
Late Pregnancy ◽  
Maternal Plasma ◽  
Vitamin D Metabolites ◽  
Pregnant Rats ◽  
Dihydroxyvitamin D ◽  
Fetal Plasma ◽  
And Control

ABSTRACT The effect of thyroparathyroidectomy (TPTX) on the plasma concentrations of the vitamin D metabolites (25-(OH)D, 24,25-(OH)2D and 1,25-(OH)2D) has been studied in pregnant rats and their fetuses during the last quarter of gestation. Maternal and fetal vitamin D metabolites were not significantly affected by TPTX. A significant increase in plasma 1,25-(OH)2D concentrations was observed in both TPTX and control mothers and fetuses from days 19 to 21. Fetal and maternal plasma 25-(OH)D were positively correlated in both control and TPTX groups. Such a correlation was also found for 24,25-(OH)2D in the two groups. In contrast, a positive correlation between maternal and fetal plasma concentrations of 1,25-(OH)2D was found in TPTX but not in control rats. These data suggest that major alterations in calcium metabolism, such as that produced by maternal TPTX, are insufficient to affect the changes in maternal and fetal plasma 1,25-(OH)2D during late pregnancy significantly. They also suggest that parathyroid hormone, thyroxine, and/or calcitonin may control a possible placental transfer of 1,25-(OH)2D in the rat. J. Endocr. (1988) 116, 381–385

Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy

1992 ◽  
Vol 127 (4) ◽  
pp. 359-365 ◽  
Author(s):  
Toshiro Kubota ◽  
Shusaku Kamada ◽  
Makoto Taguchi ◽  
Takeshi Aso
Keyword(s):  
Amniotic Fluid ◽  
Umbilical Vein ◽  
Maternal Plasma ◽  
Cross Reactivity ◽  
Main Peak ◽  
Gel Chromatography ◽  
High Concentration ◽  
Maternal Circulation ◽  
Human Pregnancy ◽  
Fetal Plasma

In order to clarify the roles of insulin-like growth factors (IGFs) on the human maternal-fetal environment, IGF-2 and IGF-1 levels were investigated in human plasma and amniotic fluid during pregnancy. Initially, new radio-immunoassay (RIA) systems for human IGF-2 could be developed. The sensitivity of this assay was 17.5 pg/tube and the cross-reactivity with IGF-1 was 0.64%. The pattern of change of maternal plasma IGF-2 in early pregnancy differed from that of IGF-1, but both IGF levels increased progressively in the second half of gestation, and decreased to non-pregnancy levels in the puerperium. Maternal levels of IGF-2 were approximately seven times greater than those of IGF-1. The ratio of IGF-2 to IGF-1 was 3.2 in amniotic fluid. The IGF concentrations in amniotic fluid obtained in the second trimester were significantly greater than those of term specimens, and closely related to those of prolactin (PRL) in amniotic fluid. The highest IGF-2 to IGF-1 ratio (1 5.9) was found in umbilical vein plasma. On Sephadex G-150 gel-chromatography of maternal and fetal plasma at term, two apparent peaks of unsaturated IGF-2 binding protein (BP) could be detected in both 150 and 40 kilo dalton (kD) regions. One main peak of unsaturated IGF-2 BP could be determined in the 40 kD region in the amniotic fluid at term. High concentration of IGF-2 could be detected in feto-maternal circulation during human pregnancy. Moreover, it is strongly suggested that the releasing systems of IGFs in amniotic fluid are different from those in maternal or umbilical circulation.

Diamine oxidase activity in human maternal and fetal plasma and tissues at parturition

1965 ◽  
Vol 20 (5) ◽  
pp. 1048-1051 ◽  
Author(s):  
A. Louis Southren ◽  
Yutaka Kobayashi ◽  
Paul Brenner ◽  
Allan B. Weingold
Keyword(s):  
Amniotic Fluid ◽  
Premature Infants ◽  
Oxidase Activity ◽  
Diamine Oxidase ◽  
Maternal Plasma ◽  
Full Term ◽  
Fetal Plasma ◽  
Paired Samples ◽  
Diamine Oxidase Activity ◽  
The Mean

The human maternal-to-fetal plasma diamine oxidase (DAO) ratio was measured in 48 paired samples from full-term pregnancies. A radioassay procedure was employed. The over-all mean maternal-to-fetal (M/F) ratio was 166/1. In a series of 12 premature deliveries the mean M/F ratio was 21/1. The low M/F ratio in the latter group was due to a high mean plasma DAO titer in the premature infants. The relative DAO content of the various trophoblastic and decidual tissues and fluids at parturition in decreasing order of activity, were as follows: decidua = 5,200, membranes = 4,100, placenta = 1,400, amniotic fluid = 100, maternal plasma = 42, cord = 14, and fetal plasma = 1. The accumulated data support the concept of a decidual origin of pregnancy DAO. radioassay of diamine oxidase; prematurity; trophoblastic and decidual tissues; amniotic fluid Submitted on September 2, 1964

Short-term fluctuations in the concentration of cortisol and progesterone in fetal plasma, maternal plasma, and amniotic and allantoic fluids from sheep during late pregnancy

1981 ◽  
Vol 59 (3) ◽  
pp. 261-267 ◽  
Author(s):  
J. R. G. Challis ◽  
J. E. Patrick ◽  
Jill Cross ◽  
J. Workewych ◽  
E. Manchester ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Allantoic Fluid ◽  
Late Pregnancy ◽  
Maternal Plasma ◽  
Significant Rise ◽  
Short Term ◽  
Fetal Plasma ◽  
Two Fluids ◽  
Paired Samples ◽  
Steroid Profiles

Fluctuations in the concentrations of cortisol and progesterone in fetal plasma, maternal plasma, and amniotic and allantoic fluids were measured in samples taken at 10-min intervals over a 90-min period from three groups of sheep sampled at different times during late pregnancy. During the last 30 days of gestation there was a significant rise in the mean concentration of cortisol in fetal plasma and amniotic fluid and a significant correlation between the cortisol concentration in these two fluids. The concentration of cortisol in allantoic fluid exceeded that in amniotic fluid. The concentration of cortisol in fetal plasma varied in a pulsatile manner; however the coefficient of variation (CV) within animals was greater (36%) on days −11 to −20, relative to the day of parturition (day 0), than on days −21 to −30 or days −5 to 0 (15–19%). The CV values for cortisol in amniotic fluid and maternal plasma during the last 30 days of pregnancy were 20–50% and two to five times greater than the intraassay CV. The concentration of progesterone in amniotic fluid increased after day −20 but was not correlated with that in maternal plasma or fetal plasma. The concentrations of progesterone in paired samples of amniotic fluid and allantoic fluid were similar. The CV values for progesterone (18–34%) were similar in fetal and maternal plasma and amniotic fluid and did not change significantly during late pregnancy. Changes in the concentration of progesterone were unrelated to changes in cortisol. Interpretation of steroid profiles in fetal plasma and fluids through late pregnancy should take into account these short-term fluctuations in hormone concentrations.

Corticotropin-releasing factor in the ovine fetus and pregnant ewe: role of placenta

1991 ◽  
Vol 261 (4) ◽  
pp. R995-R1002 ◽  
Author(s):  
M. Keller-Wood ◽  
C. E. Wood
Keyword(s):  
Adrenocorticotropic Hormone ◽  
Plasma Concentrations ◽  
Late Pregnancy ◽  
Maternal Plasma ◽  
Corticotropin Releasing Factor ◽  
Late Gestation ◽  
Fetal Plasma ◽  
Ovine Fetus ◽  
Arterial Plasma ◽  
Pregnant Ewe

In the sheep, maternal plasma adrenocorticotropic hormone and cortisol are increased in late pregnancy, and fetal plasma cortisol and adrenocorticotropic hormone rise precipitously in late gestation. To test whether the ovine placenta secretes corticotropin-releasing factor (CRF) into either the maternal or fetal circulation, pregnant ewes and their fetuses were prepared with femoral arterial catheters and uterine and umbilical venous catheters. Samples were taken from all sites before and during hypoxia. There was no difference in CRF concentration across the placenta in the mothers or the fetuses under resting or hypoxemic conditions, but maternal and fetal arterial plasma CRF concentrations increased between 128 and 145 days. In a second study, maternal and fetal femoral venous plasma CRF concentrations were measured 1-19 days before spontaneous parturition. The mean concentration increased 8.6 +/- 0.6 pg/ml 11-19 days before parturition to 13.0 +/- 1.0 and 13.2 +/- 1.4 pg/ml in fetuses 4-8 and 1-3 days before parturition, respectively. Maternal plasma concentrations did not significantly increase in the days closer to parturition. These studies demonstrate that there are low but measurable CRF concentrations in fetal and maternal sheep plasma but that these are not the result of tonic placental secretion of CRF.

scholarly journals Corticotrophin-releasing hormone and ACTH levels in maternal and fetal blood during spontaneous and oxytocin-induced labour

2001 ◽  
Vol 144 (2) ◽  
pp. 117-121 ◽  
Author(s):  
T Ochedalski ◽  
K Zylinska ◽  
T Laudanski ◽  
A Lachowicz
Keyword(s):  
Umbilical Vein ◽  
Maternal Plasma ◽  
Stress Factors ◽  
Plasma Acth ◽  
Releasing Hormone ◽  
Umbilical Vessels ◽  
Fetal Plasma ◽  
Second Stage ◽  
Second Stage Of Labour ◽  
The Mean

The changes in corticotrophin-releasing hormone (CRH), ACTH and dehydroepiandrosterone (DHEA) in maternal and fetal plasma were estimated in women undergoing spontaneous and oxytocin-induced labour to correlate hormone changes with the mode of parturition. Blood was sampled from a maternal peripheral vein 2 days before labour, during the second stage of labour and on the second postnatal day, and also from umbilical vessels just after delivery. Hormone concentrations were measured by RIA and ELSA methods. The maternal plasma CRH concentration before labour was significantly higher in the group of women delivered spontaneously and declined during the labour through to the second postnatal day. Measured in umbilical vessels, CRH as well as ACTH concentrations were higher in the umbilical vein than artery. The mean maternal plasma ACTH was similar in both groups before delivery, then increased significantly in both groups during the labour, decreasing on the second day after delivery. There were no changes in DHEA concentrations among the groups and at all time points of collection. No correlations between CRH and ACTH or DHEA were observed. Our results suggest that the maternal pituitary can respond to stress factors during delivery but peripheral CRH, probably mainly of placental origin, is not a major modulator of pituitary action.

Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy

1987 ◽  
Vol 114 (3) ◽  
pp. 497-501 ◽  
Author(s):  
D. Economides ◽  
E. Linton ◽  
K. Nicolaides ◽  
C. H. Rodeck ◽  
P. J. Lowry ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Venous Blood ◽  
Inverse Correlation ◽  
Maternal Blood ◽  
Maternal Plasma ◽  
Immunoradiometric Assay ◽  
Releasing Hormone ◽  
Fetal Plasma ◽  
Trimester Pregnancy ◽  
The Mean

ABSTRACT Samples of maternal blood, amniotic fluid and umbilical arterial and venous blood were collected from 11 women at 16–24 weeks of pregnancy. Corticotrophin-releasing hormone-41 (CRH-41) and ACTH were measured by immunoradiometric assay. The mean levels of ACTH were 11 pmol/l in maternal plasma, 12 pmol/l in fetal plasma and 9·7 pmol/l in amniotic fluid. The mean levels of CRH-41 were 1·6 pmol/l in maternal plasma and 0·7 pmol/l in fetal plasma. There was a positive correlation between maternal and fetal plasma CRH-41 and between maternal CRH-41 and ACTH. In fetal plasma there was a weak inverse correlation between CRH-41 and ACTH. This is the first demonstration of CRH-41 in the circulation of the mid-trimester human fetus, but on the basis of the present findings it is not possible to specify the exact source (fetal, placental or maternal). J. Endocr. (1987) 114, 497–501

Endocrine and fluid-balance responses to amniotic and allantoic fluid loss in sheep

1990 ◽  
Vol 259 (4) ◽  
pp. R745-R752 ◽  
Author(s):  
K. A. Dickson ◽  
S. B. Hooper ◽  
I. C. McMillen ◽  
R. Harding
Keyword(s):  
Amniotic Fluid ◽  
Fluid Balance ◽  
Arginine Vasopressin ◽  
Plasma Concentrations ◽  
Plasma Osmolality ◽  
Allantoic Fluid ◽  
Maternal Plasma ◽  
Fetal Plasma ◽  
Arterial Blood ◽  
Urine Production

Our aim was to determine fetal and maternal endocrine and fluid-balance responses to prolonged loss of amniotic and allantoic fluids in sheep. In seven sheep, amniotic and allantoic fluids were drained [379.1 +/- 20.1 (SE) ml/day] from 107 to 135.3 +/- 0.6 days of gestation (term: 145 days). The results from these sheep were compared with those from seven control sheep. Maternal water intake, urine production, and urine osmolality were not altered by fluid drainage, nor were fetal and maternal arterial blood gases, pH, or plasma osmolalities. Fluid drainage increased amniotic, but not allantoic, fluid osmolality. Maternal plasma cortisol concentration increased with fluid drainage, but maternal plasma concentrations of prolactin and arginine vasopressin were unchanged. Fluid drainage increased prolactin concentrations in fetal plasma and amniotic fluid, but fetal plasma concentrations of cortisol (hydrocortisone), arginine vasopressin, norepinephrine, and epinephrine were unchanged. Our results show that the fetus is capable of maintaining its plasma osmolality despite prolonged loss of fluid from its amniotic and allantoic sacs and that this is associated with alterations in the production rate and the composition of amniotic fluid.

scholarly journals Pre-implantation exogenous progesterone and pregnancy in sheep. II. Effects on fetal-placental development and nutrient transporters in late pregnancy

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Katherine M. Halloran ◽  
Emily C. Hoskins ◽  
Claire Stenhouse ◽  
Robyn M. Moses ◽  
Kathrin A. Dunlap ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Corn Oil ◽  
Allantoic Fluid ◽  
Late Pregnancy ◽  
Maternal Plasma ◽  
Nutrient Transporters ◽  
Placental Development ◽  
Blastocyst Development ◽  
Fetal Plasma ◽  
Exogenous Progesterone

Abstract Background Administration of progesterone (P4) to ewes during the first 9 to 12 days of pregnancy accelerates blastocyst development by day 12 of pregnancy, likely due to P4-induced up-regulation of key genes in uterine epithelia responsible for secretion and transport of components of histotroph into the uterine lumen. This study determined if acceleration of blastocyst development induced by exogenous P4 during the pre-implantation period affects fetal-placental development on day 125 of pregnancy. Suffolk ewes (n = 35) were mated to fertile rams and assigned randomly to receive daily intramuscular injections of either corn oil vehicle (CO, n = 18) or 25 mg progesterone in CO (P4, n = 17) for the first 8 days of pregnancy. All ewes were hysterectomized on day 125 of pregnancy and: 1) fetal and placental weights and measurements were recorded; 2) endometrial and placental tissues were analyzed for the expression of candidate mRNAs involved in nutrient transport and arginine metabolism; and 3) maternal plasma, fetal plasma, allantoic fluid, and amniotic fluid were analyzed for amino acids, agmatine, polyamines, glucose, and fructose. Results Treatment of ewes with exogenous P4 did not alter fetal or placental growth, but increased amounts of aspartate and arginine in allantoic fluid and amniotic fluid, respectively. Ewes that received exogenous P4 had greater expression of mRNAs for SLC7A1, SLC7A2, SLC2A1, AGMAT, and ODC1 in endometria, as well as SLC1A4, SLC2A5, SLC2A8 and ODC1 in placentomes. In addition, AZIN2 protein was immunolocalized to uterine luminal and glandular epithelia in P4-treated ewes, whereas AZIN2 localized only to uterine luminal epithelia in CO-treated ewes. Conclusions This study revealed that exogenous P4 administered in early pregnancy influenced expression of selected genes for nutrient transporters and the expression of a protein involved in polyamine synthesis on day 125 of pregnancy, suggesting a ‘programming’ effect of P4 on gene expression that affected the composition of nutrients in fetal-placental fluids.

Plasma Levels of Neopterin and Biopterin in the Umbilical Vessels and the Maternal Vein

Pteridines ◽  
2003 ◽  
Vol 14 (1) ◽  
pp. 1-4
Author(s):  
Naoko Iwanaga ◽  
Seiichi Yamamasu ◽  
Daisuke Tachibana ◽  
Junko Nishio ◽  
Yuichiro Nakai ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
High Performance ◽  
Umbilical Artery ◽  
Umbilical Vein ◽  
Aromatic Amino Acids ◽  
Maternal Plasma ◽  
Chromatography Method ◽  
Fetal Plasma ◽  
Significant Difference ◽  
Liquid Chromatography Method

Abstract Tetrahydrobiopterin (BH4) is a highly bioactive pterin required for nitric oxide synthase and monooxygenases of aromatic amino acids, and is involved in the synthesis of nitric oxide, catecholamines and Serotonin. Although these functions imply that pterin metabolism plays critical roles in human development, the intrauterine metabolism is unclear. To elucidate the pterin metabolism in the human feto-placental unit, blood was obtained from the umbilical artery and vein, and the maternal vein, and plasma biopterin and neopterin concentrations were analyzed by the high-performance liquid chromatography method. To clarify the effect of labor, data was also compared between the transvaginal delivery (TV) and the caesarean delivery (CS). The levels of biopterin and the neopterin, and neopterin/biopterin ratio were higher in the fetal plasma than in the maternal plasma. Biopterin levels in the umbilical artery were higher than those in the umbilical vein. There were significant correlations in either biopterin or neopterin between the fetal plasma and the maternal plasma. There was no significant difference in the fetal pterin levels between TV and CS. The results suggest the stimulated BH4 synthesis in the fetoplacental unit, the independent homeostasis of the fetal pterin metabolism, and the possibility of dynamic movements of pterins among the fetus, the placenta and the mother.

Sign in / Sign up

Export Citation Format

Share Document